New active paclitaxel amino acids derivatives with improved water solubility

Anticancer Research

Volumn 18, Issue 4 A, 1998, Pages 2711-2716

  Paradis, Renee ^a   Pagé, Michel ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cancer; Chemotherapy; Drug; Paclitaxel; Taxol

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE G2 PHASE; DRUG CYTOTOXICITY; DRUG SOLUBILITY; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACIDS; ANIMALS; ASPARAGINE; CELL CYCLE; CELL SURVIVAL; DRUG DESIGN; FEMALE; GLUTAMINE; GLYCEROL; GLYCINE; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MOLECULAR STRUCTURE; OVARIAN NEOPLASMS; PACLITAXEL; SERINE; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; WATER;

EID: 0031809859     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wani MC, Taylor HL, Wali ME, Coggon P, McPhail AT: Plant Antitumor Agents. VI. The Isolation and Structure of Taxol, a Novel Antileukemic and Antitumor Agent from Taxus brevifolia. J Am Chem Soc 93: 2325-2327, 1971.
2. Thompson WC, Wilson L, Purich DL: Taxol induces microtubule assembly at low temperature. Cell Motil 1: 445-454, 1981.
3. Kumar N: Taxol induced polymerization of purified tubulin. Mechanism of action. J Biol Chem 256: 10435-10441, 1981.
4. Schiff PB, Horwitz SB: Taxol assembles tubulin in the absence of exogenous guanosine 5'-triphosphate of microtubule-associated proteins. Biochemistry 20: 3247-3252, 1981.
5. Schiff PB, Fant J, Horwitz SB: Promotion of microtubules assembly in vitro by taxol. Nature 277; 665-667, 1979
6. Schiff PB, Horwitz SB: Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl Acad Sci 77: 1561-1565, 1980.
7. Manfredi JJ, Parness J, Horwitz SB: Taxol binds to cellular microtubules. Journal of Cell Biology 94: 688-696, 1982.
8. Jacrot M, Riondel J, Picot F, Leroux D, Mouriquand C, Beriel H, Potier P: Action of taxol on human tumors transplanted in athymic mice. C. R. Seances Acad Sci III 297: 597-600, 1983.
9. Wiernick PH, Schwartz EL, Strauman JJ, Dutcher JP, Lipton RB, Paietta E: Phase I clinical and pharmacokinetic study of taxol. Cancer Res 47: 2486-2493, 1987.
10. Einzig AI, Wiernik PH, Schwartz EL: Taxol: a new agent active in melanoma and ovarian cancer. Cancer Treat Res 58: 89-100, 1991.
11. Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN: Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83: 1797-1805, 1991.
12. Mc Guire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, Donehower RC: Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 111: 273-279, 1989.
13. Markman M: Taxol: an important new drug in the management of epithelial ovarian cancer. Yale J Biol Med 64: 583-590, 1991.
14. Einzig AI, Wiernik PH, Sasloff J, Runowicz CD, Goldberg GL: Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma. J Clin Oncol 10: 1748-1753, 1992.
15. Lorenz W, Reimann H-J, Schmal A, Dormann P, Schwarz B, Neugebauer E, Doenicke A: Histamine release in dogs by cremophor E1 and its derivatives: oxethylated oleic acid is the most effective constituent. Agents and Actions 7: 63-67, 1977.
16. Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, Baker JRJr, Van-Echo DA, Von-Hoff DD, Leyland-Jones B: Hypersensitivity reactions from taxol. J Clin Oncol 8: 1263-1268, 1990.
17. Mathew AE, Mejillano MP, Nath JP, Himes RH, Stella VJ: Synthesis and Evaluation of Some Water-Soluble Prodrugs and Derivatives of Taxol with Antitumor Activity. J Med Chem 35: 145-151, 1992.
18. Deutsch HM, Glinski JA, Hernandez M, Haugwitz RD, Narayanan vL, Suffness M, Zalkow LH: Synthesis of Congeners and Prodrugs. 3. Water-Soluble Prodrugs of Taxol with Potent Antitumor Activity J Med Chem 32: 788-792, 1989.
19. Magri NF, Kingston DGI: Modified Taxols, 4. Synthesis and biological activity of taxols modified in the side chain. J Nat Prod 51: 298-306, 1988.
20. Parness J, Kingston DGI, Powell RG, Harracksingh C, Horwik SB: Structure-activity study of cytotoxicity and microtubule assembly in vitro by taxol and related taxanes. Biochem Biophys Res Comm 105: 1082-1089, 1982.
21. Zhao Z, Kingston KGI: Modified taxols, 6. Preparation of water-soluble prodrugs of taxol. J Nat Prod 54: 1607-1611, 1991.
22. Pagé B, Pagé M, Noel C: A New Fluorometric Assay for Cytotoxicity Measurements in vitro. Int J Oncol 3: 473-476,1993.
23. Swindell CS, Krauss NE, Horwitz SB, Ringel I: Biologically Active Taxol Analogues with Deleted A-Ring Side Chain Substituents and Variable C-2' Configurations. J Med Chem 34: 1176-1184, 1991.
24. Banaszek A, Krowicki K, Zamojski A: Thin-layer and column chromatography of erythromycins and some degradation products. J Chromatogr 32: 581-583, 1968. 18
25. MacLennan A, Randall HM, Smith DW: Detection and identification of deoxysugars on paper chromatograms. Anal Chem 31: 2020-2022, 1959.
26. Horwitz SB, Cohen D, Rao S, Ringel I, Shen HJ, Yang CP: Taxol: mechanisms of action and resistance. J Natl Cancer Inst Monogr 15: 55-61, 1993.